Related Experiment Video
Updated: May 6, 2026

04:36
Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
Published on: April 14, 2026
310
Novel heavy tamponade for vitreoretinal surgery
Rachel L Williams1, Victoria R Kearns, Amy C Lo
1Department of Eye and Vision Science, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom.
Investigative Ophthalmology & Visual Science
|October 17, 2013
Summary
Researchers developed a heavy, optically clear tamponade using silica and phenyl trimethicone. This new agent offers enhanced tamponade efficiency and biocompatibility, suitable for ophthalmic surgery.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Retinal Surgery
Background:
- Intraocular tamponade agents are crucial in retinal detachment repair.
- Current agents like silicone oil have limitations in specific gravity and handling.
- Development of novel heavy, clear tamponades is needed for improved surgical outcomes.
Purpose of the Study:
- To create a heavy tamponade with specific gravity > 1.06 g/mL.
- To ensure optical transparency and simple manufacturing.
- To achieve suitable injectability and biocompatibility for clinical use.
Main Methods:
- Aerosil silica was incorporated into phenyl trimethicone.
- Mixing methods included roller, overhead stirring, and ultrasonics.
- Evaluated refractive index, viscosity, injectability, tamponade efficiency, and biocompatibility (in vitro and in vivo).
Main Results:
- Produced tamponades with specific gravities from 1.10 to 1.16 g/mL and good optical clarity.
- Overhead stirring yielded reproducible, stable agents with 1000-5000 mPa·s viscosity.
- Demonstrated superior tamponade efficiency and easier injection compared to existing agents.
- Showed no in vitro cytotoxicity, but noted early cataract formation and retinal changes similar to Polydimethylsiloxane 1000 (PDMS 1000).
Conclusions:
- A heavy, clear tamponade with appropriate viscosity, injectability, and enhanced efficiency was successfully produced.
- The developed tamponade exhibits biocompatibility comparable to PDMS 1000.
- This novel agent shows promise for ophthalmic surgical applications.

